insights_auto
Why is MANKIND down 3,07%?
Dive Deeperchevron_right
MANKIND:NSE
Mankind Pharma Ltd
₹2.275,50
arrow_downward
-3,07%(-72,10) 1D
16 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2.349,90
High
₹2.354,40
Low
₹2.268,70
Mkt. cap
937,40 ຕື້
Avg. vol.
483,95 ພັນ
Volume
889,73 ພັນ
P/E ratio
46,04
52-wk high
₹2.642,00
52-wk low
₹1.909,70
EPS
₹49,42
No. of employees
20 ພັນ
Open
₹2.349,90
High
₹2.354,40
Low
₹2.268,70
Mkt. cap
937,40 ຕື້
Avg. vol.
483,95 ພັນ
Volume
889,73 ພັນ
P/E ratio
46,04
52-wk high
₹2.642,00
52-wk low
₹1.909,70
EPS
₹49,42
No. of employees
20 ພັນ
News stories
From web sources and news partners
finchannel
·
46 ນາທີກ່ອນ
Apollo Commercial Real Estate Finance expects final NYSE trading on November 6
ChartMill
·
31 ນາທີກ່ອນ
PepsiCo (NASDAQ:PEP): A Quality Stock With Mixed Growth and Cash Metrics
Simply Wall Street
·
37 ນາທີກ່ອນ
Mobile Wallet Payouts Change The Bull Case For DLocal (DLO)
CNN
·
14 ຊົ່ວໂມງກ່ອນ
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20,5 ພັນ
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com